Insider Shareholders with Direct Ownership of Brickell Biotech, Inc. (BBI)
This section provides a comprehensive overview of the insiders with direct ownership of Brickell Biotech, Inc. (BBI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Brickell Biotech, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
> 10% Shareholder |
2,160,500 | 2,190,500 | 2,170,000 $3.82 Million | 14 |
Jan 10, 2019
Reduced 50.24%
|
| 1,086,412 | 0 | 1,739,412 $3.06 Million | 42 |
Jun 10, 2024
Added 4.72%
|
|
| 0 | 30,000 | 700,000 $1.23 Million | 3 |
Dec 06, 2023
Reduced 2.4%
|
|
|
Reginald L Hardy
CHAIRMAN OF THE BOARD |
247,435 | 20,053 | 433,231 $762,486 | 5 |
Dec 31, 2021
Reduced 3.39%
|
|
Robert Busard Brown
Chief Executive Officer |
100,000 | 0 | 186,957 $329,044 | 1 |
Mar 15, 2021
Added 34.85%
|
|
Andrew D Sklawer
President and CEO |
90,375 | 27,833 | 39,269 $69,113 | 5 |
Oct 02, 2023
Reduced 34.66%
|
|
Deepak Chadha
Former Chief R&D Officer & COO |
75,200 | 23,728 | 22,314 $39,272 | 6 |
Sep 01, 2023
Reduced 40.16%
|
|
Vijay B Samant
Director |
0 | 4,408 | 19,134 $33,675 | 1 |
Dec 31, 2020
Reduced 18.72%
|
|
Gary A Lyons
Director |
0 | 5,967 | 18,762 $33,021 | 1 |
Dec 31, 2020
Reduced 24.13%
|
|
David R. Mc Avoy
Gen Counsel, CCO, & Secretary |
81,746 | 16,108 | 16,061 $28,267 | 6 |
Oct 02, 2023
Reduced 31.42%
|
|
Jose Breton
Chief Accounting Officer |
15,000 | 5,250 | 11,919 $20,977 | 2 |
Mar 16, 2021
Reduced 30.58%
|
|
Aaron Fox Colis
VP of Finance & CAO |
0 | 110 | 0 $0 | 2 |
Dec 08, 2023
Reduced 100.0%
|